MDX — Medx Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$16.40m
- CA$24.35m
- CA$0.47m
Annual cashflow statement for Medx Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.32 | -5.13 | -4.58 | -3.65 | -6.29 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.78 | 1.74 | 1.9 | 1.49 | 2.87 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.025 | 0.545 | -0.789 | -0.392 | -0.357 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.52 | -2.8 | -3.42 | -2.51 | -3.73 |
| Capital Expenditures | -0.016 | 0 | — | 0 | -0.002 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.016 | 0 | — | 0 | -0.002 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.6 | 2.84 | 3.42 | 2.53 | 3.59 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.069 | 0.036 | -0.004 | 0.02 | -0.14 |